Primary myelofibrosis is not primary anymore since the discovery of MPL515 and CALR mutations as driver causes of mono-linear megakaryocytic and dual megakaryocytic granulocytic myeloproliferation and secondary myelofibrosis
Open Access
- 15 April 2019
- journal article
- Published by Heighten Science Publications Corporation
- Vol. 2 (1), 018-026
- https://doi.org/10.29328/journal.ijbmr.1001003
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Europeanvs2015-World Health Organization clinical molecular and pathological classification of myeloproliferative neoplasmsWorld Journal of Hematology, 2015
- Changing Concepts of Diagnostic Criteria of Myeloproliferative Disorders and the Molecular Etiology and Classification of Myeloproliferative Neoplasms: From Dameshek 1950 to Vainchenker 2005 and BeyondActa Haematologica, 2014
- JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomesBlood, 2014
- CALR vs JAK2 vs MPL-mutated or triple-negative myelofibrosis: clinical, cytogenetic and molecular comparisonsLeukemia, 2014
- 2014 WHO Clinical Molecular and Pathological (WHO-CMP) Diagnostic Criteria for the Classification and Staging of Five Distinct JAK2, MPL and CALR Mutated Myeloproliferative NeoplasmsJournal of Hematology & Thromboembolic Diseases, 2014
- Somatic Mutations of Calreticulin in Myeloproliferative NeoplasmsThe New England Journal of Medicine, 2013
- JAK2V617F mutation and allele burden are associated with distinct clinical and morphological subtypes in patients with essential thrombocythaemiaJournal of Clinical Pathology, 2012
- One Thousand Patients With Primary Myelofibrosis: The Mayo Clinic ExperienceMayo Clinic Proceedings, 2012
- The 2001 World Health Organization and Updated European Clinical and Pathological Criteria for the Diagnosis, Classification, and Staging of the Philadelphia Chromosome-Negative Chronic Myeloproliferative DisordersSeminars in Thrombosis and Hemostasis, 2006
- Clinical and Pathological Criteria for the Diagnosis of Essential Thrombocythemia, Polycythemia Vera, and Idiopathic Myelofibrosis (Agnogenic Myeloid Metaplasia)International Journal of Hematology, 2002